Pamprin Multi-Symptom

Product NDC: 71687-3003
11-digit product format: 716873003
Labeler code: 71687
Product ID: 71687-3003_4fe8f1cd-8250-e908-e063-6394a90a1173
Type: HUMAN OTC DRUG
Nonproprietary name: Acetaminophen, Pamabrom, Pyrilamine maleate
Dosage form: TABLET
Route: ORAL
Labeler: Focus Consumer Healthcare, LLC
Application: M013
Marketing category: OTC MONOGRAPH DRUG
Marketing start: 2016-06-01
Substance: PYRILAMINE MALEATE; PAMABROM; ACETAMINOPHEN
Active strength: 15; 25; 500 mg/1; mg/1; mg/1
NDC exclude flag: No
Listing certified through: 2027-12-31
Current FDA listing: Yes

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 21 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Code	Status	Snapshot	Source SHA-256
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	71687-3003-4	I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	71687-3003-1	I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	71687-3003-4	I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	71687-3003-1	I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	71687-3003-4	I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	71687-3003-1	I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	71687-3003-4	I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	71687-3003-1	I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		U	Excluded because listing certification expired	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	71687-3003-4	U	Excluded because listing certification expired	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	71687-3003-1	U	Excluded because listing certification expired	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		U	Excluded because listing certification expired	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	71687-3003-4	U	Excluded because listing certification expired	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	71687-3003-1	U	Excluded because listing certification expired	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		U	Excluded because listing certification expired	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	71687-3003-4	U	Excluded because listing certification expired	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	71687-3003-1	U	Excluded because listing certification expired	`0efc9e666f02…`	`f202fb6c5f17…`

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

Additional Listing Data#

Finished product: Yes
Brand name base: Pamprin Multi-Symptom
Brand name suffix: Maximum Strength
Listing expiration: 2027-12-31

Active Ingredients#

Ingredient, Strength table
Ingredient	Strength
PYRILAMINE MALEATE	15 mg/1
PAMABROM	25 mg/1
ACETAMINOPHEN	500 mg/1

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 3 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
R35D29L3ZA	Internal UNII lookup
UA8U0KJM72	Internal UNII lookup
362O9ITL9D	Internal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 2 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
1052637	Internal RxNorm lookup
1053852	Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
60b3286d-5698-df50-e053-2991aa0afbe2	Available on FDA.report

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Related label table
NDC	Effective	Related label
71687-3003-1	2025-04-14	Pamprin MultiSymptom
71687-3003-4	2025-04-14	Pamprin MultiSymptom
71687-3003-1	2025-01-30	Pamprin MultiSymptom
71687-3003-4	2025-01-30	Pamprin MultiSymptom

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	SPL version
71687-3003-1	Pamprin Multi-SymptomMaximum Strength	20 in 1 BOTTLE, PLASTIC	TABLET	20	5
71687-3003-1	Pamprin Multi-SymptomMaximum Strength	1 in 1 CARTON	TABLET	1	5
71687-3003-4	Pamprin Multi-SymptomMaximum Strength	1 in 1 CARTON	TABLET	1	5
71687-3003-4	Pamprin Multi-SymptomMaximum Strength	40 in 1 BOTTLE, PLASTIC	TABLET	40	5

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
71687-3003	PAMPRIN MULTI-SYMPTOM MAXIMUM STRENGTH (ACETAMINOPHEN, PAMABROM, PYRILAMINE MALEATE) TABLET [FOCUS CONSUMER HEALTHCARE, LLC]	4	Current NDC, Legacy NDC, 4 package rows	20250416_60b3286d-5698-df50-e053-2991aa0afbe2.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 31 of 83 · 1,657 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Pain Relief PM Extra Strength	ACETAMINOPHEN AND DIPHENHYDRAMINE HYDROCHLORIDE	HEB	f7958347-4e9c-4698-8749-7ca7023ee2ba	2025-12-09	Warnings	Exact identifier application number: M013
Pain Relief Rapid Release Gelcaps Extra Strength	ACETAMINOPHEN	Safeway	c830d1ac-c4c5-4eb1-98bb-22707cb6db91	2025-12-09	Warnings	Exact identifier application number: M013
Menstrual Pain Relief Complete	ACETAMINOPHEN, PYRILAMINE MALEATE, CAFFEINE	Shield Pharmaceuticals Corp	5efd6c61-74ed-4253-896a-e4a40bd8f25b	2025-12-09	Warnings	Exact identifier application number: M013
Excedrin Extra Strength, TRAVEL BASIX	ACETAMINOPHEN, ASPIRIN, AND CAFFEINE	Lil Drug Store Products, Inc	7f0f8b3c-c226-4a3a-af46-a708f345e4f5	2025-12-09	Warnings	Exact identifier application number: M013
childrens acetaminophen	ACETAMINOPHEN	United Natural Foods, Inc. dba UNFI	f65203a2-64f0-4138-97e4-6eab99194178	2025-12-09	Warnings	Exact identifier application number: M013
Pain Reliever PM, Extra Strength, 24-7 Life by 7-Eleven	ACETAMINOPHEN, DIPHENHYDRAMINE HCL TABLET, FILM COATED	Lil' Drug Store Products, Inc.	45735cd8-ac07-3f12-e063-6294a90a0cb2	2025-12-08	Warnings	Exact identifier application number: M013
BERKLEY AND JENSEN RAPID RELEASE ACETAMINOPHEN	ACETAMINOPHEN	BJWC	e27b6637-ef32-44b5-a531-b6617d02fbbf	2025-12-08	Warnings	Exact identifier application number: M013
Pain Reliever	ACETAMINOPHEN	WALGREENS	3f9f1740-9e8b-6a2d-e063-6294a90a67cb	2025-12-06	Warnings	Exact identifier application number: M013
Bayer Rapid Relief	ASPIRIN/CAFFEINE ORAL POWDER	Bayer HealthCare LLC.	f1fecbb0-5b55-fe8f-e053-2995a90a0977	2025-12-05	Warnings	Exact identifier application number: M013
Headache Relief, Extra Strength 24/7 Life by 7-Eleven	ACETAMINOPHEN, ASPIRIN, CAFFEINE TABLET, FILM COATED	Lil' Drug Store Products, Inc.	45381b1c-2acd-1524-e063-6394a90a83d9	2025-12-05	Warnings	Exact identifier application number: M013
Acetaminophen Easy Tabs Extra Strength	ACETAMINOPHEN	United Natural Foods, Inc. dba UNFI	729132cd-f209-447a-8949-a90b5a5c01da	2025-12-05	Warnings	Exact identifier application number: M013
Menstrual Pain Relief Complete	ACETAMINOPHEN, PYRILAMINE MALEATE, CAFFEINE	Shield Pharmaceuticals Corp	05fda811-d65f-41b2-89e4-297cdddb3d99	2025-12-05	Warnings	Exact identifier application number: M013
aspirin	ASPIRIN	Health Pharma USA, LLC	3165b0a3-556b-6abe-e063-6394a90a7682	2025-12-04	Warnings	Exact identifier application number: M013
Bayer Genuine Aspirin	ASPIRIN	Bayer HealthCare LLC.	44a08904-68b9-4d06-a28d-21aae3d6140c	2025-12-04	Warnings	Exact identifier application number: M013
Extra Strength Acetaminophen	ACETAMINOPHEN	Geri-Care Pharmaceutical Corp	7a29dde6-a177-6206-e053-2991aa0a01f2	2025-12-04	Warnings	Exact identifier application number: M013
Extra Strength Pain Relief	ACETAMINOPHEN	Geri-Care Pharmaceutical Corp	7570aaa2-3238-4cd3-b788-915caa970dba	2025-12-04	Warnings	Exact identifier application number: M013
Bayer Headache	ASPIRIN AND CAFFEINE	Bayer HealthCare LLC.	c0a92873-0914-6a86-e053-2995a90ac41c	2025-12-04	Warnings	Exact identifier application number: M013
Alka-Seltzer Original Flavor	ALKA-SELTZER ORIGINAL FLAVOR	Bayer HealthCare LLC.	07478020-5ba0-3b67-e054-00144ff88e88	2025-12-04	Warnings	Exact identifier application number: M013
Alka-Seltzer Plus Severe Sinus Cold and Cough Liquid Gels	ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, PHENYLEPHRINE HYDROCHLORIDE	Bayer HealthCare LLC.	0dba1329-5b0d-5688-e054-00144ff8d46c	2025-12-04	Warnings	Exact identifier application number: M013
Alka-Seltzer Plus Cold Medicine Sparkling Original	ASPIRIN, CHLORPHENIRAMINE MALEATE, AND PHENYLEPHRINE BITARTRATE	Bayer HealthCare LLC.	78537dcf-b157-4b67-a8b2-5cb144815166	2025-12-04	Warnings	Exact identifier application number: M013

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
R35D29L3ZA	PYRILAMINE MALEATE	59-33-6	PYRILAMINE MALEATE
UA8U0KJM72	PAMABROM	606-04-2	PAMABROM
362O9ITL9D	ACETAMINOPHEN	103-90-2	ACETAMINOPHEN

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
1052637	acetaminophen 500 MG / pamabrom 25 MG / pyrilamine maleate 15 MG Oral Tablet	PSN	60b3286d-5698-df50-e053-2991aa0afbe2	5
1053852	Pamprin Max Strength Multi-Symptom 500 MG / 25 MG / 15 MG Oral Tablet	PSN	60b3286d-5698-df50-e053-2991aa0afbe2	5
1053852	acetaminophen 500 MG / pamabrom 25 MG / pyrilamine maleate 15 MG Oral Tablet [Pamprin Multi-Symptom]	SBD	60b3286d-5698-df50-e053-2991aa0afbe2	5
1052637	acetaminophen 500 MG / pamabrom 25 MG / pyrilamine maleate 15 MG Oral Tablet	SCD	60b3286d-5698-df50-e053-2991aa0afbe2	5
1052637	APAP 500 MG / pamabrom 25 MG / pyrilamine maleate 15 MG Oral Tablet	SY	60b3286d-5698-df50-e053-2991aa0afbe2	5
1053852	APAP 500 MG / pamabrom 25 MG / Pyrilamine Maleate 15 MG Oral Tablet [Pamprin Multi-Symptom]	SY	60b3286d-5698-df50-e053-2991aa0afbe2	5
1053852	Pamprin Multi-Symptom (APAP 500 MG / pamabrom 25 MG / pyrilamine maleate 15 MG) Oral Tablet	SY	60b3286d-5698-df50-e053-2991aa0afbe2	5

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Marketing start	Marketing end	Sample	Exclude flag	Status
71687-3003-1	71687300301	1 BOTTLE, PLASTIC in 1 CARTON (71687-3003-1) / 20 TABLET in 1 BOTTLE, PLASTIC	2016-06-01	0000-00-00	No	No	Current
71687-3003-4	71687300304	1 BOTTLE, PLASTIC in 1 CARTON (71687-3003-4) / 40 TABLET in 1 BOTTLE, PLASTIC	2016-06-01	0000-00-00	No	No	Current